JONATHAN AYERS Buys 0.06% of IDXX

Submitted: 2011-10-06 16:12:09 EST

--

On 2011-10-06, a Form 4 was filed with the SEC that indicated that JONATHAN AYERS had bought a total of 40,000 shares of Idexx Laboratories Inc /de (IDXX). The total value of this transaction was $2,461,280.

JONATHAN AYERS, who currently serves as CHAIRMAN, PRESIDENT & CEO at Idexx Laboratories Inc /de, now owns 307,697 shares of the company. Here is the breakdown:

Direct Ownership - 307,697


There were a total of 6 transactions included in this filing:

Buys:

2011-10-04, BOUGHT 20,000 (Common Stock) @ $12.6 (Exercise or Conversion of Derivative)

2011-10-05, BOUGHT 20,000 (Common Stock) @ $12.6 (Exercise or Conversion of Derivative)



Sells:

2011-10-04, SOLD 9,500 (Common Stock) @ $64.2054 (Open Market Sale)

2011-10-04, SOLD 5,500 (Common Stock) @ $64.5939 (Open Market Sale)

2011-10-05, SOLD 14,597 (Common Stock) @ $66.1209 (Open Market Sale)

2011-10-05, SOLD 403 (Common Stock) @ $66.7387 (Open Market Sale)



Idexx Laboratories Inc /de (IDXX) is currently trading at $69.86 (+2.08%). The 52 week high for IDXX is $87.29, while its 52 week low is $59.65.

Some information that you might find useful about Idexx Laboratories Inc /de:

Market Cap: 3.97B
Forward P/E: 22.75
Price/Book: 6.39
EBITDA: 272.11M
Total Cash: 159.40M
Total Debt: 137.46M
52 Week Change: -1.37%
Float: 9.60%
Shares Short: 4.37M
Short Ratio: 11.60

Source: Davemanuel.com - IDXX Quote

Source: SEC.gov - JONATHAN AYERS Form 4 Filing